This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 May 22;309(20):2091-2.

doi: 10.1001/jama.2013.4541.

End points in trials of treatments for skin infections

PMID: 23695471
DOI: 10.1001/jama.2013.4541

Comment

End points in trials of treatments for skin infections

Brad Spellberg. JAMA. 2013.

. 2013 May 22;309(20):2091-2.

doi: 10.1001/jama.2013.4541.

Author

PMID: 23695471
DOI: 10.1001/jama.2013.4541

No abstract available

PubMed Disclaimer

Comment in

End points in trials of treatments for skin infections--reply.
Prokocimer P, Das A. Prokocimer P, et al. JAMA. 2013 May 22;309(20):2092. doi: 10.1001/jama.2013.4550. JAMA. 2013. PMID: 23695472 No abstract available.

Comment on

Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.
Prokocimer P, De Anda C, Fang E, Mehra P, Das A. Prokocimer P, et al. JAMA. 2013 Feb 13;309(6):559-69. doi: 10.1001/jama.2013.241. JAMA. 2013. PMID: 23403680 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations